Envíe este artículo por correo electrónico (Inicie sesión)
Enviar un correo electrónico al autor/a (Inicie sesión) Open Journal Systems
Apnea obstructiva del sueño e hipertensión arterial. Las evidencias de su relación
Resumen
En esta revisión se analiza la relación entre la apnea obstructiva del sueño y la hipertensión arterial sistémica. Se exponen las evidencias epidemiológicas de la alteración respiratoria y de su asociación con la hipertensión arterial, las interacciones fisiopatológicas entre ambas condiciones, los métodos diagnósticos y el impacto del tratamiento sobre la fisiopatología y el pronóstico.
Palabras clave
Referencias
Arredondo A, Avilés R. Hypertension and its effects on the economy of the health system for patients and society: suggestions for developing countries. Am J Hypertension. 2014;27(4):635-6.
González-Pliego JA, Gutierrez-Díaz GI, Celis A, Gudiño-Amezcua DA. Registro de síndromes coronarios agudos sin elevación del segmento ST en un centro hospitalario de tercer nivel de atención (estudio RESCATA-SEST). Arch Cardiol Mex. 2014;84(2):92-9.
Juárez-Herrera U, Jerjes-Sánchez C. Risk factors, therapeutic approaches, and in-hospital outcomes in Mexicans with ST-elevation acute myocardial infarction: the RENASICA II multicenter study. Clin Cardiol. 2013;36(5):241-8.
Somers VK, White DP, Amin R, Abraham WT, Costa F, Culebras A, et al. Sleep apnea and cardiovascular disease: an American Heart Association/American College of Cardiology Foundation Scientific Statement from the American Heart Association Council for High Blood Pressure Research Professional Education Committee, Council on Clinical Cardiology, Stroke Council, and Council on Cardiovascular Nursing. In collaboration with the National Heart, Lung, and Blood Institute National Center on Sleep Disorders Research (National Institutes of Health). J Am Coll Cardiol. 2008;52(8):686-717.
Dudenbostel T, Calhoun DA. Resistant hypertension, obstructive sleep apnea and aldosterone. J Hum Hypertens. 2012;26(5):281-7.
Epstein LJ, Kristo D, Strollo Jr PJ, Friedman R, Malhotra A, Patil SP, et al. Clinical guideline for the evaluation, management and long-term care of obstructive sleep apnea in adults. J Clin Sleep Med. 2009;5(3):263-76.
Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc. 2008;5(2):136-43.
Ancoli-Israel S, Kripke DF, Klauber MR, Mason WJ, Fell R, Kaplan O. Sleep-disordered breathing in community-dwelling elderly. Sleep. 1991;14(6):486-91.
Torre-Bouscoulet L, Vázquez-García JC, Muiño A, Márquez M, López MV, Montes de Oca M, et al. Prevalence of sleep related symptoms in four Latin American cities. J Clin Sleep Med. 2008;4(6):579-85.
Rimoldi SF, Scherrer U, Messerli FH. Secondary arterial hypertension: when, who, and how to screen?. European Heart J. 2014;35(19):1245-54.
Baguet JP, Hammer L, Lévy P, Pierre H, Rossini E, Mouret S, et al. Night-time and diastolic hypertension are common and underestimated conditions in newly diagnosed apnoeic patients. J Hypertens. 2005;23(3):521-7.
Logan AG, Perlikowsky SM, Mente A, Tisler A, Tkacova R, Niroumand M, et al. High prevalence of unrecognized sleep apnea in drug-resistant hypertension. J Hypertens. 2001;19(12):2271-7.
Parati G, Ochoa JE, Bilo G, Mattaliano P, Salvi P, Karlo K, et al. Obstructive sleep apnea syndrome as a cause of resistant hypertension. Hypertens Res. 2014;37(7):601-13.
Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378-84.
Marin JM, Agusti A, Villar I, Forner M, Nieto D, Carrizo SJ, et al. Association between treated and untreated obstructive sleep apnea and risk of hypertension. JAMA. 2012;307(20):2169-76.
Somers VK, Dyken ME, Clary MP, Abboud FM. Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest. 1995;94(4):1897-904.
Pedrosa RP, Krieger EM, Lorenzi-Filho G, Drager LF. Recent advances of the impact of obstructive sleep apnea on systemic hypertension. Arq Bras Cardiol. 2011;97(2):e40-7.
Noda A, Nakata S, Koike Y, Miyata S, Kitaichi K, Nishizawa T, et al. Continuous positive airway pressure improves daytime baroreflex sensitivity and nitric oxide production in patients with moderate to severe obstructive sleep apnea syndrome. Hypertens Res. 2007;30(8):669-76.
Kohler M, Stradling JR. Mechanisms of vascular damage in obstructive sleep apnea. Nat Rev Cardiol. 2010;7(12):677-85.
Priou P, Gagnadoux F, Tesse A, Mastronardi ML, Agouni A, Meslier N, et al. Endothelial dysfunction and circulating microparticles from patients with obstructive sleep apnea. Am J Pathol. 2010;177(2):974-83.
Carlson JT, Ràngemark C, Hedner JA. Attenuated endothelium-dependent vascular relaxation in patients with sleep apnoea. J Hypertens. 1996;14(5):577-84.
Trzepizur W, Gagnadoux F, Abraham P, Rousseau P, Meslier N, Saumet JL, et al. Microvascular endotelial function in obstructive sleep apnea: impact of continuous positive airway pressure and mandibular advancement. Sleep Med. 2009;10(7):746-52.
Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep. 2008;32(4):447-70.
Drager LF, Polotsky VY, Lorenzi-Filho G. Obstructive sleep apnea: an emerging risk factor for atherosclerosis. Chest. 2011;140(2):534-42.
Baguet JP, Levy P, Barone-Rochette G, Tamisier R, Pierre H, Peeters M, et al. Masked hypertension in obstructive sleep apnea syndrome. J Hypertens. 2008;26(5):885-92.
Parati G, Lombardi C, Hedner J, Bonsignore MR, Grote L, Tkacova R, et al. Recommendations for the management of patients with obstructive sleep apnea and hypertension. Joint recommendations by the European Society of Hypertension, the European Respiratory Society and by members of European COST Action B26 on Obstructive Sleep Apnea. Eur Respir J. 2013;41(3):523-38.
Ben-Dov IZ, Kark JD, Ben-Ishay D, Mekler J, Ben-Arie L, Bursztyn M. Predictors of all-cause mortality in clinical ambulatory monitoring: unique aspects of blood pressure during sleep. Hypertension. 2007;49(6):1235-41.
Seif F, Patel SR, Walia HK, Rueschman M, Bhatt DL, Blumenthal RS, et al. Obstructive sleep apnea and diurnal nondipping hemodynamic incides in patients at increased cardiovascular risk. J Hypertens. 2014;32(2):267-75.
Ziegler MG, Milic M, Sun P. Antihypertensive therapy for patients with obstructive sleep apnea. Curr Opin Nephrol Hypertens. 2011;20(1):50-5.
Pimenta E, Calhoun DA. Treatment of resistant hypertension. J Hypertens. 2010;28(11):2194-5.
Bazzano LA, Khan Z, Reynolds K, He J. Effect of nocturnal nasal continuous positive airway pressure on blood pressure in obstructive sleep apnea. Hypertension. 2007;50(2):417-23.
Iftikhar IH, Valentine CW, Bittencourt LR, Cohen DL, Fedson AC, Gislason T, et al. Effects of continuous positive airway pressure on blood pressure in patients with resistant hypertension and obstructive sleep apnea: a meta-analysis. J Hypertens. 2014;32(12):2341-50.
Cook NR, Cohen J, Hebert PR, Taylor JO, Hennekens CH. Implications of small reductions in diastolic blood pressure for primary prevention. Arch Intern Med. 1995;155(7):701-9.
Barbé F, Durán-Cantolla J, Sánchez-de la Torre M, Martínez-Alonso M, Carmona C, Barceló A, et al. Effect of continuous positive airway pressure on the incidence of hypertension and cardiovascular events in nonsleepy patients with obstructive sleep apnea. A randomized controlled trial. JAMA. 2012;307(20):2161-8.
Rao M, Rajda G, Uppuluri S, Beck R, Liu L, Bisognano JD. The role of continuous positive airway pressure in the treatment of hypertension in patients with obstructive sleep apnea-hypoapnea syndrome: a review of randomized trials. Rev Recent Clin Trials. 2010;5(1):35-42.
Enlaces refback
- No hay ningún enlace refback.